Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority study of one-container versus two-container AS25-adjuvanted influenza vaccine in adults aged 65 years and older
2007-003290-29Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of AS25-adjuvanted influenza vaccine in influenza (2 arms), sponsored by GSK. Primary endpoints: Serum haemagglutination-inhibition antibody titer against A/New Caledonia (H1N1) and Immunologic non-inferiority based on HI antibody geometric mean titer. Started Jul 2007; status: completed.
02
Drugs
AS25-adjuvanted influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-003290-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003290-29.